daunorubicin has been researched along with Hyperplasia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aster, JC; Inhorn, RC; Roach, SA; Slapak, CA; Soiffer, R; Stone, RM; Tantravahi, R | 1 |
| Dabadghao, S; Melinkeri, SR; Mishra, SK | 1 |
| Byrnes, JJ; Downey, KM; Esserman, L; So, AG | 1 |
| Fishbein, G; Iseri, O; Knodell, RG; Rosen, AA | 1 |
| Farhi, DC; Rosenthal, NS | 1 |
| Bernard, J; Blom, J; Boiron, M; Brunner, K; Cooper, MR; Cuttner, J; Ellison, RR; Gailani, S; Glidewell, OJ; Haurani, F; Holland, JF; Hoogstraten, B; Jacquillat, C; Levy, R; Lowenstein, L; Nissen, NI; Rege, VB; Serpick, AA; Silver, RT; Wasserman, L; Weil, M; Wiernik, PH | 1 |
1 review(s) available for daunorubicin and Hyperplasia
| Article | Year |
|---|---|
A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Eosinophilia; Etoposide; Fatal Outcome; Female; Humans; Hydroxyurea; Hyperplasia; Ifosfamide; Leukemia, Myeloid; Lymph Nodes; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Syndrome; Translocation, Genetic; Vincristine | 1995 |
5 other study(ies) available for daunorubicin and Hyperplasia
| Article | Year |
|---|---|
Benign thymic hyperplasia after chemotherapy for acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Female; Humans; Hyperplasia; Leukemia, Promyelocytic, Acute; Pseudotumor Cerebri; Radiography; Sweet Syndrome; Thymus Gland; Tretinoin | 2001 |
Mechanism of hemin inhibition of erythroid cytoplasmic DNA polymerase.
Topics: Bone Marrow; Bone Marrow Cells; Cytoplasm; Daunorubicin; DNA Nucleotidyltransferases; Ethidium; Globins; Heme; Hemin; Humans; Hyperplasia; Kinetics; Rifamycins; Time Factors | 1975 |
Nodular regenerative hyperplasia: a cause of ascites and hepatomegaly after chemotherapy for leukemia.
Topics: Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Ascites; Biopsy; Cytarabine; Daunorubicin; Female; Hepatomegaly; Humans; Hyperplasia; Leukemia, Myeloid; Liver | 1991 |
Dysmegakaryopoiesis resembling acute megakaryoblastic leukemia in treated acute myeloid leukemia.
Topics: Acute Disease; Antigens, CD; Bone Marrow; Cytarabine; Daunorubicin; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Hyperplasia; Immunophenotyping; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Megakaryocytes; Mitoxantrone; Myelodysplastic Syndromes; Prognosis; Time Factors | 1991 |
Daunorubicin in the therapy of acute granulocytic leukemia.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Platelets; Blood Transfusion; Cytarabine; Daunorubicin; Female; Humans; Hydrazines; Hyperplasia; Leukemia, Myeloid; Leukocyte Count; Leukopenia; Male; Mercaptopurine; Methotrexate; Middle Aged; Remission, Spontaneous; Thrombocytopenia; Time Factors | 1973 |